1-2 of 2
Keywords: Enzyme replacement therapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Agalsidase Alfa Slows the Decline in Renal Function in Patients with Fabry Disease

Available to Purchase
Subject Area:
Nephrology
Sandro Feriozzi, Andreas Schwarting, Gere Sunder-Plassmann, Michael West, Markus Cybulla
Journal: American Journal of Nephrology
Am J Nephrol (2009) 29 (5): 353–361.
https://doi.org/10.1159/000168482
Published Online: 31 October 2008
...Sandro Feriozzi; Andreas Schwarting; Gere Sunder-Plassmann; Michael West; Markus Cybulla The aim of this study was to determine the effects of enzyme replacement therapy with agalsidase α on renal function in patients with Fabry nephropathy. Serum creatinine data were collected from 165 adult...
View articletitled, Agalsidase Alfa Slows the Decline in Renal Function in Patients with Fabry Disease
Open the PDF for Agalsidase Alfa Slows the Decline in Renal Function in Patients with Fabry Disease in another window
Journal Articles

Molecular Etiology of Primary Hyperoxaluria Type 1: New Directions for Treatment

Available to Purchase
Subject Area:
Nephrology
Christopher J. Danpure
Journal: American Journal of Nephrology
Am J Nephrol (2005) 25 (3): 303–310.
https://doi.org/10.1159/000086362
Published Online: 01 July 2005
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Primary hyperoxaluria type 1 Alanine:glyoxylate aminotransferase AGXT Liver transplantation Enzyme replacement therapy Pyridoxine Gene therapy Chemical chaperones...
View articletitled, Molecular Etiology of Primary Hyperoxaluria Type 1: New Directions for Treatment
Open the PDF for Molecular Etiology of Primary Hyperoxaluria Type 1: New Directions for Treatment in another window